// App-Quantinova.ai

1169 : Thrombin Generation Assay Is Superior to Traditional Coagulometric and Chromogenic Assays to Monitor New Oral Anticoagulants

Researchers

Presenter

  • Jonathan Douxfils

Principal Investigators

  • Christian Chatelain

  • Bernard Chatelain

  • Jean-Michel Dogne

Medical Centers

  • Pharmacy,Namur Thrombosis and Hemostasis Center NTHC, Namur Research Institute for LIfe Sciences NARILIS, Facultes Universitaires Notre Dame de la Paix, Namur, Belgium

  • Department of Pharmacy, University of Namur, Namur Research Institute for LIfe Sciences NARILIS, Namur, Belgium

  • Hematology laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences NARILIS, Yvoir, Belgium

  • Hematology laboratory, UCL Mont-Godinne, Namur Research Institute for LIfe Sciences NARILIS, Yvoir, Belgium

Locations

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • Cancer antigen 15-3

  • Catalase

  • Coagulation Factor III, Tissue Factor

  • Prothrombin

Drug/Treatment

  • Pradax

  • rivaroxaban

  • apixaban

  • Edoxaban

  • Methadone hydrochloride

  • Evithrom

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved